Company Overview

WELL Health Technologies Corp. is a Canadian healthcare technology and services company focused on digital health, primary care, and healthcare enablement solutions. The company operates across the healthcare and health technology industries, combining ownership and operation of outpatient medical clinics with software platforms and digital tools used by healthcare providers. WELL’s core activities include electronic medical records (EMR), telehealth, patient engagement software, cybersecurity services for healthcare organizations, and primary healthcare delivery through clinic networks. Its revenue is generated from a mix of clinical services, recurring software subscriptions, licensing, digital health services, and healthcare practitioner support solutions.

The company has evolved from a clinic-focused healthcare operator into a diversified digital healthcare platform through a series of acquisitions and strategic investments. WELL has emphasized consolidation within fragmented healthcare technology and outpatient care markets, particularly in Canada and the United States. Its positioning is supported by ownership of healthcare infrastructure assets, integration of technology with clinical operations, and a strategy centered on practitioner enablement rather than direct insurance or pharmaceutical exposure. Public disclosures in SEC filings, Canadian securities filings, and investor materials consistently describe the company’s strategy as focused on digitizing and modernizing healthcare workflows while expanding recurring software revenue.

Business Operations

WELL operates through multiple business lines that include Canadian Patient Services, U.S. Healthcare Services, and Digital Services and Technology Platforms. The company owns and operates a network of primary care, specialty care, and diagnostic clinics in Canada while also maintaining healthcare operations in the United States through acquisitions and affiliated entities. Revenue is generated through insured healthcare services, practitioner billings, software licensing, telehealth consultations, cybersecurity services, and healthcare SaaS offerings. The company has also developed a physician enablement model designed to integrate clinical care delivery with digital infrastructure and operational support.

Its technology portfolio includes EMR platforms, cybersecurity offerings, billing software, patient communication systems, and virtual care technologies. WELL has controlled or invested in subsidiaries and affiliated businesses including CRH Medical Corporation, WISP, Circle Medical, and MyHealth Partners, among others disclosed in public filings. The company has pursued partnerships with healthcare providers, physician groups, and technology vendors to expand service distribution and interoperability capabilities. WELL’s operational model relies heavily on acquisition integration and cross-selling digital tools into its clinical and practitioner networks.

Strategic Position & Investments

WELL’s strategic direction has centered on becoming a vertically integrated healthcare technology platform with recurring software and services revenue. The company has pursued aggressive acquisition-led growth in both Canada and the United States, targeting outpatient healthcare operators, digital health platforms, and physician workflow software businesses. Acquisitions such as CRH Medical Corporation expanded WELL’s exposure to gastroenterology and anesthesia services in the U.S., while investments in virtual care and women’s health platforms broadened its digital healthcare footprint.

The company has also invested in artificial intelligence-enabled healthcare tools, cybersecurity services, and interoperability solutions intended to improve provider productivity and patient engagement. Public company disclosures indicate an emphasis on scalable SaaS revenue, practitioner retention, and healthcare digitization trends. WELL has maintained exposure to emerging healthcare technology sectors including telehealth, AI-assisted clinical workflow systems, and digital patient engagement. Some strategic initiatives and financial performance expectations discussed in investor materials are forward-looking in nature and remain dependent on integration execution and market conditions.

Geographic Footprint

WELL is headquartered in Vancouver, Canada, and maintains operations primarily across Canada and the United States. In Canada, the company operates clinics and healthcare technology services across multiple provinces, including significant activity in British Columbia, Ontario, and Alberta. Its Canadian operations include primary care clinics, specialty healthcare facilities, and EMR solutions used by physicians and healthcare organizations.

In the United States, WELL expanded through acquisitions in specialty care, telehealth, and digital healthcare services. The company’s U.S. presence includes healthcare service operations and technology businesses serving providers and patients nationally. WELL’s broader market presence reflects increasing exposure to North American healthcare digitization trends, though the majority of its operational footprint and strategic focus remains concentrated in Canadian and U.S. healthcare systems.

Leadership & Governance

WELL was founded and is led by entrepreneur Hamed Shahbazi, who has played a central role in shaping the company’s acquisition strategy and digital healthcare focus. Leadership communications and corporate disclosures consistently emphasize modernization of healthcare delivery, practitioner enablement, and long-term recurring revenue growth through technology integration. The company operates as a publicly traded corporation listed on the Toronto Stock Exchange under the symbol WELL and maintains governance practices aligned with Canadian public market requirements.

Key executives identified in recent public filings and corporate disclosures include:

• Hamed Shahbazi – Founder, Chairman, and Chief Executive Officer
• Eva Fong – Chief Financial Officer
• Amir Javidan – Chief Operating Officer
• Claus Torp Jensen – Chief Innovation Officer
• Michael Frankel – Chief Executive Officer of WELL Health USA

Leadership structure and executive responsibilities may evolve over time based on acquisitions, organizational integration, and operational restructuring disclosed in public filings.